1. Janus kinase inhibitors and biosimilars for rheumatoid arthritis: final policy recommendations Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, January 9, 2020 Subject(s): Arthritis, Rheumatoid -- drug therapyJanus Kinase InhibitorsUnited States